Loading...
•
Mar 31, 2022
Pediatrix Q1 2022 Earnings Report
Mednax reported a loss from continuing operations of $0.25 per share for the three months ended March 31, 2022.
Key Takeaways
Mednax reported net revenue of $482 million and a loss from continuing operations of $21 million. Adjusted EPS from continuing operations was $0.33, and Adjusted EBITDA was $51 million. The company's bottom line results were in line with expectations, reflecting continued patient volume growth.
Net revenue was $482 million.
Loss from continuing operations was $21 million.
Adjusted EBITDA was $51 million.
Adjusted EPS from continuing operations was $0.33.
Forward Guidance
No forward guidance provided in this report.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...